Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Dimitrios Patoulias Theodoros MichailidisAthina DimosiariNikolaos FragakisGary Tse Manfredi Rizzo

Published in: Biomedicines (2023)

Treatment with GLP-1RAs can significantly improve weight loss and other cardiometabolic risk factors in obese people taking antipsychotic medications.

Keyphrases

weight loss
risk factors
bariatric surgery
roux en y gastric bypass
gastric bypass
adipose tissue
weight gain
obese patients
metabolic syndrome
glycemic control
type diabetes
newly diagnosed
wild type
body mass index
replacement therapy
combination therapy
emergency department
skeletal muscle